Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.
Related Research units
Abstract
The role of hemoglobin levels as an independent prognostic marker of progression to AIDS and/or death in HIV-infected patients starting combination antiretroviral therapy (cART) was investigated. A total of 2,579 patients from the EuroSIDA cohort with hemoglobin, CD4 cell count, and HIV RNA viral load measured 6 months prior to starting cART was included in the analyses. Anemia was defined as mild (
Bibliographical data
| Original language | German |
|---|---|
| Article number | 10 |
| ISSN | 0889-2229 |
| Publication status | Published - 2007 |
| pubmed | 17961102 |
|---|
